337 related articles for article (PubMed ID: 29593708)
1. Mucosal Delivery of Fusion Proteins with
Copland A; Diogo GR; Hart P; Harris S; Tran AC; Paul MJ; Singh M; Cutting SM; Reljic R
Front Immunol; 2018; 9():346. PubMed ID: 29593708
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-Fusion Protein Complexes Protect against Mycobacterium tuberculosis Infection.
Hart P; Copland A; Diogo GR; Harris S; Spallek R; Oehlmann W; Singh M; Basile J; Rottenberg M; Paul MJ; Reljic R
Mol Ther; 2018 Mar; 26(3):822-833. PubMed ID: 29518353
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Bacillus subtilis spores for the delivery of Mycobacterium tuberculosis Ag85B-CFP10 secretory antigens.
Das K; Thomas T; Garnica O; Dhandayuthapani S
Tuberculosis (Edinb); 2016 Dec; 101S():S18-S27. PubMed ID: 27727129
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model.
Sibley L; Reljic R; Radford DS; Huang JM; Hong HA; Cranenburgh RM; Cutting SM
FEMS Microbiol Lett; 2014 Sep; 358(2):170-9. PubMed ID: 24990572
[TBL] [Abstract][Full Text] [Related]
5. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
[TBL] [Abstract][Full Text] [Related]
6. Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates.
White AD; Tran AC; Sibley L; Sarfas C; Morrison AL; Lawrence S; Dennis M; Clark S; Zadi S; Lanni F; Rayner E; Copland A; Hart P; Diogo GR; Paul MJ; Kim M; Gleeson F; Salguero FJ; Singh M; Stehr M; Cutting SM; Basile JI; Rottenberg ME; Williams A; Sharpe SA; Reljic R
Front Immunol; 2023; 14():1246826. PubMed ID: 37881438
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
9. Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization.
Thakur A; Rodríguez-Rodríguez C; Saatchi K; Rose F; Esposito T; Nosrati Z; Andersen P; Christensen D; Häfeli UO; Foged C
Front Immunol; 2018; 9():2825. PubMed ID: 30555488
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
[TBL] [Abstract][Full Text] [Related]
11. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity.
Dietrich J; Andersen C; Rappuoli R; Doherty TM; Jensen CG; Andersen P
J Immunol; 2006 Nov; 177(9):6353-60. PubMed ID: 17056566
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
[TBL] [Abstract][Full Text] [Related]
13. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine.
Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA
Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592
[TBL] [Abstract][Full Text] [Related]
14. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
Wang J; Thorson L; Stokes RW; Santosuosso M; Huygen K; Zganiacz A; Hitt M; Xing Z
J Immunol; 2004 Nov; 173(10):6357-65. PubMed ID: 15528375
[TBL] [Abstract][Full Text] [Related]
15. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
[TBL] [Abstract][Full Text] [Related]
16. Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice.
Chuang YM; Pinn ML; Karakousis PC; Hung CF
Front Cell Infect Microbiol; 2018; 8():31. PubMed ID: 29473022
[No Abstract] [Full Text] [Related]
17. Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.
Hu Z; Wong KW; Zhao HM; Wen HL; Ji P; Ma H; Wu K; Lu SH; Li F; Li ZM; Shu T; Xu JQ; Lowrie DB; Fan XY
Mol Ther; 2017 May; 25(5):1222-1233. PubMed ID: 28342639
[TBL] [Abstract][Full Text] [Related]
18. Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
Back YW; Choi S; Choi HG; Shin KW; Son YJ; Paik TH; Kim HJ
PLoS One; 2019; 14(3):e0213536. PubMed ID: 30849108
[TBL] [Abstract][Full Text] [Related]
19. Enhanced protection against pulmonary mycobacterial challenge by chitosan-formulated polyepitope gene vaccine is associated with increased pulmonary secretory IgA and gamma-interferon(+) T cell responses.
Ai W; Yue Y; Xiong S; Xu W
Microbiol Immunol; 2013 Mar; 57(3):224-35. PubMed ID: 23489083
[TBL] [Abstract][Full Text] [Related]
20. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against
Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C
J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
